½ÃÀ庸°í¼­
»óǰÄÚµå
1593033

¼¼°èÀÇ Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå : ¸ð´Þ¸®Æ¼, Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Intravascular Ultrasound Market by Modality (iMap IVUS, Integrated Backscatter IVUS, Virtual Histology IVUS), Product (Accessories, Consoles), End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀåÀº 2023³â¿¡ 8¾ï 6,964¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 9¾ï 1,095¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.12%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 12¾ï 3,429¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç÷°ü³» ÃÊÀ½ÆÄ(IVUS)´Â ÁÖ·Î ½ÉÇ÷°ü Ä¡·á¿¡¼­ °ü»ó µ¿¸ÆÀ» ³»ºÎ¿¡¼­ ¿ÜºÎ·Î ½Ã°¢È­ÇÏ´Â µ¥ »ç¿ëµÇ´Â °í±Þ À̹Ì¡ ±â¼ú·Î Ç÷°ü ÁúȯÀÇ Á¸Àç¿Í Á¤µµ¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. IVUSÀÇ Çʿ伺Àº Ç÷°üº®ÀÇ »ó¼¼ÇÑ ´Ü¸é ¿µ»óÀ» Á¦°øÇÏ´Â ´É·Â¿¡ ÀÖ¾î, º´º¯ÀÇ ÁßÁõµµ, ÇöóÅ©ÀÇ Á¶¼º, ºÐÆ÷¸¦ Á¤È®ÇÏ°Ô Æò°¡ÇÏ´Â °ÍÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÀýÂ÷ÀÇ Á¤È®¼º Çâ»ó À̸¦ À§ÇØ º´¿ø, Àü¹® Ŭ¸®´Ð, ¿¬±¸±â°ü µî¿¡¼­ Æø³Ð°Ô ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇʵåÀÇ ¼ºÀåÀº °íÇØ»óµµ À̹ÌÁö¿Í IVUS¿Í ´Ù¸¥ Áø´Ü ¾ç½Ä°úÀÇ ÅëÇÕ°ú °°Àº ±â¼ú Çõ½Å¿¡ ÀÇÇØ ´õ¿í ÃËÁøµË´Ï´Ù. ½ÃÀå È®´ë¿¡ ¹æÇذ¡ µÉ ¼ö ÀÖÀ½ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ´Â ½ÅÈï ±¹°¡¿¡¼­ IVUSÀÇ Ã¤Åà Ȯ´ë¿Í ¸»ÃÊ µ¿¸Æ°ú ½ÉÀåÀÇ ±¸Á¶Àû Áúº´¿¡ ´ëÇÑ ÀÎÅͺ¥¼Ç¿¡¼­ IVUSÀÇ ÀÀ¿ë È®´ë°¡ ÁÖ¸ñµË´Ï´Ù. ÇÁ·Î ¹ÙÀÌ´õ¿ÍÀÇ Àü·«Àû Á¦ÈÞ¿Í »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇÑ R&D ÅõÀÚ¸¦ ÅëÇØ ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤¹Ðµµ ±×¸®°í È¿À²À» ³ôÀÌ´Â AI ÁÖµµÇü À̹ÌÁö ÇØ¼®ÀÇ °³¹ß, ÈÞ´ë¿ë IVUS ½Ã½ºÅÛÀÇ °³¹ß, »ýºÐÇØ¼º ¾àÁ¦ ¿ëÃâ IVUS Ä«Å×ÅÍÀÇ Å½±¸ µîÀÌ ÀÖ½À´Ï´Ù. ¼¶À¯ À¯ÁöÇϱâ À§ÇØ ¼­ºñ½ºÀÇ ÆøÀ» ³ÐÇô¾ßÇÕ´Ï´Ù. IVUS ½ÃÀå¿¡ ´ëÇÑÀÌ »ó¼¼ÇÑ ÀλçÀÌÆ®Àº ¼ºÀåÀ» °¡¼ÓÇÏ°í ½ÉÀåÇ÷°ü Ä¡·á¸¦ ÀçÁ¤ÀÇÇϱâ À§ÇØ Çõ½ÅÀûÀÎ Á¢±Ù¹ýÀÇ µµÀÔ°ú ±âÁ¸ Á¦ÇÑÀÇ ¿ÏÈ­ »çÀÌÀÇ ±ÕÇü °­Á¶ÇÏ´Â °ÍÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 8¾ï 6,964¸¸ ´Þ·¯
¿¹Ãø³â(2024) 9¾ï 1,095¸¸ ´Þ·¯
¿¹Ãø³â(2030) 12¾ï 3,429¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 5.12%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. Á¤±³È­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ½ÉÇ÷°ü ÁúȯÀÇ À¯Çà
    • °íÇØ»óµµ À̹Ì¡ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
    • Àúħ½À ÀÇ·á¿¡ÀÇ °æ»ç
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ç÷°ü³» ÃÊÀ½ÆÄ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú »óȯÀÇ Á¦ÇÑ
  • ½ÃÀå ±âȸ
    • ¸ÂÃãÇü ÀÇ·á¿Í ¿ø°Ý ÀÇ·áÀÇ »õ·Î¿î µ¿Çâ
    • Ç÷°ü³» ÃÊÀ½ÆÄÀÇ ±â¼úÀû Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • Ç÷°ü³» ÃÊÀ½ÆÄ ¼³°èÀÇ º¹À⼺

Porter's Five Forces : Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷Áö¼Å´×À» ºÐ¸íÈ÷ ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ß ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

Ç÷°ü ³» ÃÊÀ½ÆÄ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü
      • °íÇØ»óµµ Áø´Ü À̹ÌÁö ¼Ö·ç¼Ç ¼ö¿ä Áõ°¡
      • Àúħ½À ÀÇ·á óġ¿¡ÀÇ °æÇâ
    • ¾ïÁ¦¿äÀÎ
      • Ç÷°ü³» ÃÊÀ½ÆÄ¿Í °ü·ÃµÈ ºñ¿ëÀÌ ³ô°í ȯºÒÀÌ Á¦ÇѵǾî ÀÖ´Ù
    • ±âȸ
      • ¸ÂÃãÇü ÀÇ·á¿Í ¿ø°Ý ÀÇ·áÀÇ »õ·Î¿î Æ®·»µå
      • Ç÷°ü³» ÃÊÀ½ÆÄ¿¡¼­ÀÇ ±â¼úÀû Áøº¸
    • °úÁ¦
      • µðÀÚÀÎÀÇ º¹À⼺ Ç÷°ü³» ÃÊÀ½ÆÄ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ¾ÆÀÌ¸Ê IVUS
  • ÅëÇÕ ÈÄ¹æ »ê¶õ IVUS
  • °¡»ó Á¶Á÷ÇÐ IVUS

Á¦7Àå Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå : Á¦Ç°º°

  • ¾×¼¼¼­¸®
    • Ä«Å×ÅÍ
    • °¡À̵å¿ÍÀ̾î
  • ÄܼÖ

Á¦8Àå Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • Çмú¿¬±¸±â°ü
  • È­»ó Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷°ü³» ÃÊÀ½ÆÄ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • ACIST Medical Systems
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CIVCO Medical Instruments Co. Inc.
  • Conavi Medical Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE HealthCare Technologies, Inc.
  • Germitec SA
  • Hologic, Inc.
  • Infraredx, Inc.
  • Infraredx, Inc. by Nipro Company
  • Koninklijke Philips NV
  • Lantheus Holdings, Inc.
  • Mindray Medical International Limited
  • Siemens Healthineers AG
  • SonoScape Medical Corp.
  • Stryker Corporation
  • Terumo Corporation
BJH 24.11.22

The Intravascular Ultrasound Market was valued at USD 869.64 million in 2023, expected to reach USD 910.95 million in 2024, and is projected to grow at a CAGR of 5.12%, to USD 1,234.29 million by 2030.

Intravascular Ultrasound (IVUS) is an advanced imaging technique used chiefly in cardiovascular care to visualize coronary arteries from the inside-out, providing critical insights into the presence and extent of vascular diseases. The necessity of IVUS lies in its ability to offer detailed cross-sectional images of vessel walls, facilitating accurate assessment of lesion severity, plaque composition, and distribution, which are indispensable in diagnosing and crafting treatment strategies for coronary artery disease. IVUS finds its application across hospitals, specialty clinics, and research institutions, enhancing the precision of interventional procedures like angioplasty and stenting. The market for IVUS is being driven by the increasing prevalence of cardiovascular diseases, rising awareness about minimally invasive diagnostic tools, and advancements in imaging technology. Market growth is further propelled by technological innovations such as high-resolution imaging and the integration of IVUS with other diagnostic modalities. However, challenges such as the high cost of devices, the complexity of interpretation, and the need for skilled practitioners may hinder market expansion. In terms of potential opportunities, the growing adoption of IVUS in emerging economies and its expanding application in peripheral artery and structural heart disease interventions are noteworthy. Companies can leverage these opportunities through strategic partnerships with healthcare providers and by investing in R&D to develop user-friendly, cost-effective solutions. Innovations likely to yield business growth include the development of AI-driven imaging analysis to enhance accuracy and efficiency, creation of portable IVUS systems, and exploration of biodegradable, drug-eluting IVUS catheters. The market's competitive nature necessitates players to focus on continuous technological advancement and broaden their service offerings to maintain a competitive edge. This detailed insight into the IVUS market underscores the balance between embracing innovative practices and mitigating existing limitations to catalyze growth and redefine cardiovascular care.

KEY MARKET STATISTICS
Base Year [2023] USD 869.64 million
Estimated Year [2024] USD 910.95 million
Forecast Year [2030] USD 1,234.29 million
CAGR (%) 5.12%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravascular Ultrasound Market

The Intravascular Ultrasound Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cardiovascular diseases worldwide
    • Growing need for high-resolution diagnostic imaging solutions
    • Inclination towards minimally invasive medical procedures
  • Market Restraints
    • High cost associated with intravascular ultrasound and limited reimbursement
  • Market Opportunities
    • Emerging trend of personalized medicine and telemedicine
    • Technological advancements in intravascular ultrasound
  • Market Challenges
    • Complexity in designing intravascular ultrasound

Porter's Five Forces: A Strategic Tool for Navigating the Intravascular Ultrasound Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravascular Ultrasound Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravascular Ultrasound Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravascular Ultrasound Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravascular Ultrasound Market

A detailed market share analysis in the Intravascular Ultrasound Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravascular Ultrasound Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravascular Ultrasound Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravascular Ultrasound Market

A strategic analysis of the Intravascular Ultrasound Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravascular Ultrasound Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACIST Medical Systems, Avinger, Inc., B. Braun SE, Boston Scientific Corporation, Canon Medical Systems Corporation, CIVCO Medical Instruments Co., Inc., Conavi Medical Inc., Esaote SpA, Fujifilm Corporation, GE HealthCare Technologies, Inc., Germitec S.A., Hologic, Inc., Infraredx, Inc., Infraredx, Inc. by Nipro Company, Koninklijke Philips N.V., Lantheus Holdings, Inc., Mindray Medical International Limited, Siemens Healthineers AG, SonoScape Medical Corp., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intravascular Ultrasound Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Modality, market is studied across iMap IVUS, Integrated Backscatter IVUS, and Virtual Histology IVUS.
  • Based on Product, market is studied across Accessories and Consoles. The Accessories is further studied across Catheters and Guidewires.
  • Based on End-Use, market is studied across Academic & Research Institutes, Diagnostic Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular diseases worldwide
      • 5.1.1.2. Growing need for high-resolution diagnostic imaging solutions
      • 5.1.1.3. Inclination towards minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with intravascular ultrasound and limited reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging trend of personalized medicine and telemedicine
      • 5.1.3.2. Technological advancements in intravascular ultrasound
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in designing intravascular ultrasound
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravascular Ultrasound Market, by Modality

  • 6.1. Introduction
  • 6.2. iMap IVUS
  • 6.3. Integrated Backscatter IVUS
  • 6.4. Virtual Histology IVUS

7. Intravascular Ultrasound Market, by Product

  • 7.1. Introduction
  • 7.2. Accessories
    • 7.2.1. Catheters
    • 7.2.2. Guidewires
  • 7.3. Consoles

8. Intravascular Ultrasound Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Hospitals

9. Americas Intravascular Ultrasound Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravascular Ultrasound Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravascular Ultrasound Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACIST Medical Systems
  • 3. Avinger, Inc.
  • 4. B. Braun SE
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. CIVCO Medical Instruments Co., Inc.
  • 8. Conavi Medical Inc.
  • 9. Esaote SpA
  • 10. Fujifilm Corporation
  • 11. GE HealthCare Technologies, Inc.
  • 12. Germitec S.A.
  • 13. Hologic, Inc.
  • 14. Infraredx, Inc.
  • 15. Infraredx, Inc. by Nipro Company
  • 16. Koninklijke Philips N.V.
  • 17. Lantheus Holdings, Inc.
  • 18. Mindray Medical International Limited
  • 19. Siemens Healthineers AG
  • 20. SonoScape Medical Corp.
  • 21. Stryker Corporation
  • 22. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦